The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

WP3 - Severe Autoimmune Diabetes (SAID) - mechanisms & pathways

WP leaders
 

Åke Lernmark and Annelie Carlsson

Objectives

  • To explore the influence of SAID heterogeneity on disease outcome
  • To identify targetable mechanisms and pathways underlying initiation and progression of SAID
  • To identify predictive biomarkers for the development of other concomitant autoimmune disease

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Press releases

Publications

DiaUnion, the Medicon Valley Center for diabetes, autoimmunity and prevention

  • Started in winter 2020, will run for 2.5 years
  • Funded by the European Regional Development Fund
  • Partners are Lund University, Steno Diabetes Center Copenhagen, Medicon Valley Alliance, The Capital Region of Denmark and Region Skåne
  • https://mva.org/projects/diaunion/